Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
Kuen Kuen Lam, Siew Heng Wong, Peh Yean Cheah
Cells (2023) Vol. 12, Iss. 4, pp. 631-631
Open Access | Times Cited: 10

Showing 10 citing articles:

In Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches
Amar Ajmal, Muhammad Danial, Maryam Zulfat, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 551-551
Open Access | Times Cited: 6
Correlation of MRI characteristics with KRAS mutation status in pancreatic ductal adenocarcinoma
Junjian Shen, Xingxing Wang, Kaifan Yu, et al.
Abdominal Radiology (2025)
Closed Access
Evolution of computational techniques against various KRAS mutants in search for therapeutic drugs: a review article
Asif Mehmood, Mohammed Ageeli Hakami, Hanan A. Ogaly, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access
An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors in Cancer Therapy
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 4, pp. 362-364
Open Access | Times Cited: 2
Targeted Degradation of KRASG12D as Potential Therapy in Cancer
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 537-538
Open Access | Times Cited: 2
Targeting KRASG12D Mutations: Discovery of Small Molecule Inhibitors for the Potential Treatment of Intractable Cancers
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 8, pp. 1041-1042
Closed Access | Times Cited: 2
Covalent Inhibitors of MAP Kinases
Surya K. De
Drug design and discovery (2024), pp. 159-189
Closed Access
Targeting the “Undruggable” Driver Protein, KRASG12D, as Potential Therapy in Prostate Cancer
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 4, pp. 365-366
Open Access | Times Cited: 1
Discovery of Selective and Potent KRASG12D Inhibitors as Potential Therapy in Cancer
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 689-691
Open Access
Unveiling New KRASG12D Inhibitors: A Promising Approach for Pancreatic Cancer Therapy
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 7, pp. 889-890
Open Access
Evaluating New Drugs against K-Ras4B/PDE6δ Using an in Vitro Approach
Dayan Andrea Carrión-Estrada, Paola Briseño-Díaz, Sandra Delfín-Azuara, et al.
Biochemistry (2023)
Open Access
Page 1

Scroll to top